COMPASS Pathways

Articles tagged with “COMPASS Pathways”

1 article

COMP360 Phase 3 Data Confirms Rapid TRD Relief

Six-month data from a second Phase 3 trial of COMP360 psilocybin confirms rapid antidepressant effects for treatment-resistant depression. What patients should know.

Jul 8, 2026

Read

Back to all articles

Need help or want to reach readers?

Have a correction, provider question, or advertising inquiry? Reach the editorial team.

Contact the site